Synonym
IDR-90104; E-2-CDS; E-2CDS; IDR 90104; E 2 CDS; E 2CDS; IDR90104; E2CDS;
IUPAC/Chemical Name
(3-Hydroxy-17-((1-methyl-1,4-dihydropyridin-3-yl)carbonyl)oxy)estra-1,3,5(10)-triene
InChi Key
KTMLJZFJHDUEAU-ZZDGKJOTSA-N
InChi Code
InChI=1S/C25H31NO3/c1-25-12-11-20-19-8-6-18(27)14-16(19)5-7-21(20)22(25)9-10-23(25)29-24(28)17-4-3-13-26(2)15-17/h3,6,8,13-15,20-23,27H,4-5,7,9-12H2,1-2H3/t20-,21-,22+,23?,25+/m1/s1
SMILES Code
C[C@@]12C(OC(C3=CN(C)C=CC3)=O)CC[C@@]1([H])[C@]4([H])CCC5=C(C=CC(O)=C5)[C@@]4([H])CC2
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
393.53
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Prokai-Tatrai K, Szarka S, Nguyen V, Sahyouni F, Walker C, White S, Talamantes T, Prokai L. "All in the mind"? Brain-targeting chemical delivery system of 17β-estradiol (Estredox) produces significant uterotrophic side effect. Pharm Anal Acta. 2012;Suppl 7. doi: 10.4172/2153-2435.S7-002. PubMed PMID: 24380028; PubMed Central PMCID: PMC3874273.
2: Patthy M, Seres G, Tóth-Sarudy E, Hazai I, Pallagi I, Simay A, Bodor N. Determination of estredox, a compound with sustained estradiol function, and its impurity profile by HPLC. Pharmazie. 2008 Mar;63(3):210-6. PubMed PMID: 18444509.
3: Sziráki I, Horváth K, Bodor N. Comparative evaluation of Estredox, a brain-targeted estradiol delivery system versus traditional estrogen replacement therapy. Pharmazie. 2006 Feb;61(2):140-3. PubMed PMID: 16526562.
4: Tapfer MK, Sebestyen L, Kurucz I, Horvath K, Szelenyi I, Bodor N. New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox. Pharmacol Biochem Behav. 2004 Mar;77(3):423-9. PubMed PMID: 15006452.